Publications
- Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in BRCA1/BRCA2 Mutation Carriers Versus Non-Carriers2019 | First Faculty of Medicine, Third Faculty of Medicine
- Identification of deleterious germline CHEK2 mutations and their association with breast and ovarian cancer2019 | First Faculty of Medicine
- The PALB2 Gene Is a Strong Candidate for Clinical Testing in BRCA1- and BRCA2-Negative Hereditary Breast Cancer2013 | First Faculty of Medicine
- Hereditary breast cancer - an example of uncommon breast cancer in population2009 | First Faculty of Medicine
- Uptake and Effectiveness of Risk-Reducing Surgeries in Unaffected Female BRCA1 and BRCA2 Carriers: A Single Institution Experience in the Czech Republic2023 | First Faculty of Medicine
- Preservation of fertility in young patients with breast cancer, including BRCA1, BRCA2 mutation carriers2023 | First Faculty of Medicine
- Trastuzumab deruxtecan in the treatment of patients with metastatic HER2‑low breast cancer2023 | First Faculty of Medicine
- Ultrasound appearance and targeted therapy of symptomatic neural lesions in the breast and chest wall after breast cancer surgery2023 | First Faculty of Medicine
- Bilateral Prophylactic Nipple-Sparing Mastectomy: Analysis of the Risk-Reducing Effect in BRCA1/2 Mutation Carriers2022 | First Faculty of Medicine
- Komentář ke studii2022 | First Faculty of Medicine
Loading network view...